Results 41 to 50 of about 1,421,541 (309)
Background There are several national and international criteria available for identifying potentially inappropriate medications (PIMs) for older people. The prevalence of PIM use may vary depending on the criteria used.
Jasmin Paulamäki +3 more
doaj +1 more source
adults aged 80 and over, a fast growing age-group, with increased co-morbidity and frailty have not been the focus of previous research on dyspnoea. We investigate the correlates of dyspnoea and its association with adverse outcomes in a cohort of adults
Hegendörfer, Eralda +9 more
core +1 more source
Inception and deprescribing of statins in people aged over 80 years: cohort study [PDF]
Objective: Statin use over the age of 80 years is weakly evidence-based. This study aimed to estimate rates of statin inception and deprescribing by frailty level in people aged 80 years or older.
Jackson, Stephen +12 more
core +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Background In a hospital setting and among older patients, inactivity and bedrest are associated with a wide range of negative outcomes such as functional decline, increased risk of falls, longer hospitalization and institutionalization.
Plamena Tasheva +5 more
doaj +1 more source
Background Older people are often admitted for rehabilitation to improve walking, yet not everyone improves. The aim of this study was to determine key factors associated with a positive response to hospital-based rehabilitation in older people.
Catherine M Said +10 more
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
CNS relapse is reported in 2–5% of diffuse large B‐cell lymphoma (DLBCL) patients, dramatically decreasing overall survival (OS). Very few studies address incidence and risk factors of CNS relapse in very elderly patients, a challenging population to ...
Aurélie Cabannes‐Hamy +22 more
doaj +1 more source
Use of aged care services before death [PDF]
This bulletin examines people’s use of aged care services in the 8 years before death, using the cohort of 116,481 people who died in 2010–11 aged at least 65. Summary In 2010-11, 116,481 people died in Australia aged at least 65.
Australian Institute of Health and Welfare
core
Univariate and multivariate analyses of prognostic factors of overall mortality in gastric cancer patients aged over 80 years.
Seungbong Han (781387) +10 more
core +1 more source

